A study on drug-drug interaction of roxithromycin and antidiabetic drugs

Indian Drugs

Volumn 42, Issue 12, 2005, Pages 808-813

  Swami, A M ^a   Shetty, S R ^a   Kumar, S M S ^a   Rao, N V ^a  

^a V L COLLEGE OF PHARMACY   (India)

Author keywords

Alloxan; Antidiabetic activity; Drug drug interaction; Glibenclamide; Hypoglycaemic activity; Roxithromycin; Tolbutamide

Indexed keywords

EID: 77956259760     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ritz E., Orth S. R. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999; 341: 1127-33. (Pubitemid 29466226)
2. Merimee T. J. Diabetic retinopathy: A synthesis of Perspectives. N Eng J Med 1990; 322: 978-83.
3. Editorial. Coronary heart disease in patients with diabetes. N Engl J Med 2000; 342: 1040-42.
4. Joshi, Nirmal et. al. Primary care: infections with diabetes mellitus. N Engl Med 1999; 341 : 1906-12.
5. Murphy D P., Tan J S., File T M J. Infectious complications in patients with diabetes mellitus. N Engl J Med 1999; 341: 1906-12.
6. Yuan R., Parmelee T., Balian J D., Uppoor R S., Ajayi F., Burnett A., et al. In vitro interaction studies: experience of the food and drug administration. Clinical Pharmacol Ther. 1999; 66 : 9-15.
7. th Ed. 1996: 1123-53.
8. The new macrolide antibiotics. The annals of pharmacotherapy 1992: 26 (1): 46-55.
9. Von Rosensteil N A., Adam D. Macrolide antibacterial drug interactions. Drug Saf 1995; 13 (2): 105-22.
10. Lindstrom T D., Hanssen B R. Cytochrome p-450 complex formation by macrolides. Antimicrobial Agents and Chemotherapy 1993; 37 (2): 265-269.
11. Trinder P. Ann Clin Biochem 1964; 6: 24.